The induced anti-PD-L1 antibodies can kill PD-L1-expressing tumor cells by multiple mechanisms, including the inhibition of PD-L1 interaction with PD-1 on CTLs, the antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Here, CD274 is linked to neoplasm.